Ndrg2  promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma

Zhi-Qiang Ling; Ming-Hua Ge; Xiao-Xiao Lu; Jin Han; Yi-Chen Wu; Xiang Liu; Xin Zhu; Lian-Lian Hong

doi:10.18632/oncotarget.3601

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Ndrg2 promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma

Zhi-Qiang Ling _, Ming-Hua Ge, Xiao-Xiao Lu, Jin Han, Yi-Chen Wu, Xiang Liu, Xin Zhu and Lian-Lian Hong

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:8210-8225. https://doi.org/10.18632/oncotarget.3601

Metrics: PDF 2446 views | HTML 3080 views | ?

Abstract

Zhi-Qiang Ling1, Ming-Hua Ge2, Xiao-Xiao Lu1, Jin Han1, Yi-Chen Wu1, Xiang Liu1, Xin Zhu1 and Lian-Lian Hong1

1 Zhejiang Cancer Research Institute, Zhejiang Province Cancer Hospital, Zhejiang Cancer Center, Hangzhou, China

2 Department of Tumor Surgery, Zhejiang Province Cancer Hospital, Zhejiang Cancer Center, Hangzhou, China

Correspondence to:

Zhi-Qiang Ling, email:

Keywords: gastric carcinoma, Helicobacter pylori (H. pylori) infection, DNMT3b, N-myc downstream regulated gene 2 (Ndrg2), promoter methylation

Received: September 20, 2014 Accepted: February 03, 2015 Published: March 15, 2015

Abstract

N-myc downstream regulated gene 2 (Ndrg2) is a candidate suppressor of cancer metastasis. We found that Ndrg2 promoter was frequently hypermethylated in gastric cancer cell lines and in 292 gastric tumor tissues. This resulted in down-regulation of Ndrg2 mRNA and protein. Ndrg2 promoter methylation was associated with H. pylori infection and worse prognosis of gastric cancer patients, which is an independent prognostic factor for the disease-free survival (DFS). We found that H. pylori silenced Ndrg2 by activating the NF-κB pathway and up-regulating DNMT3b, promoting gastric cancer progression. These findings uncover a previously unrecognized role for H. pylori infection in gastric cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3601

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Ndrg2 promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma

Abstract